Kronos Bio Inc (KRON) — Cash Flow-to-Debt Ratio
Latest as of March 2025:
-0.45x
Kronos Bio Inc (KRON) has a Cash Flow-to-Debt Ratio of -0.45x as of March 2025, meaning its operating cash flow of $-12.84 Million could theoretically repay 0% of its total liabilities ($28.33 Million) in one year. See Kronos Bio Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.45x
Operating CF / Total Liabilities
Operating Cash Flow
$-12.84 Million
USD
Total Liabilities
$28.33 Million
USD
Data as of
Mar 2025
Most recent filing
Kronos Bio Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Kronos Bio Inc across 7 annual periods. For the full cash flow conversion analysis, see KRON cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Kronos Bio Inc (2018–2024)
Year-by-year debt coverage analysis for Kronos Bio Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.78x | $-65.44 Million | $36.78 Million | ▼ -22.7% |
| 2023 | -1.45x | $-78.58 Million | $54.20 Million | ▲ +19.6% |
| 2022 | -1.80x | $-90.93 Million | $50.44 Million | ▲ +29.1% |
| 2021 | -2.54x | $-117.92 Million | $46.38 Million | ▼ -211.5% |
| 2020 | -0.82x | $-37.91 Million | $46.45 Million | ▼ -581.3% |
| 2019 | -0.12x | $-15.08 Million | $125.89 Million | ▲ +63.0% |
| 2018 | -0.32x | $-6.44 Million | $19.91 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.